In this article, we described the development in the field of allergy as described by Clinical and Experimental Allergy in 2016. Experimental models of allergic disease, basic mechanisms, clinical mechanisms, allergens, asthma and rhinitis, and clinical allergy are all covered.
In this article, we described the development in the field of allergy Pollen is one of the most common causes of allergies, and it is thought that at least 40% of patients with allergies world-wide are sensitized to grass pollen allergens. [1] [2] [3] More than 150 pollen allergens, originating from grasses, trees, and weeds, are officially acknowledged by the IUIS allergen nomenclature subcommittee. 4 However, recent studies indicate that pollen grains contain additional protein and non-protein substances, beyond the allergen content, that have immunomodulatory activity; these substances include oxidases, proteases, pollen-associated lipid mediators (PALMs), and adenosine. 5, 6 Oxidases, including ragweed pollen NADPH oxidase, stimulate reactive oxygen species, alter airway epithelial function, and can induce allergic airway inflammation in experimental animal models. 7, 8 PALMs, which consist of monohydroxylated products of linoleic and linolenic and resemble human leukotrienes, modulate human neutrophil and eosinophil migration and dendritic cell (DC) activation. 5, 6 Adenosine stimulates CD4 + T cell priming. 9 Are these allergen-coincident immunomodulators clinically relevant?
Gilles-Stein and colleagues recently analysed the birch pollen metabolome in a protein-free, low molecular weight (LMW) fraction of aqueous birch pollen extracts (Bet-APE < 3 kDa) and identified numerous LMW compounds including lipids, hormones, sugars, and purine and pyrimidine nucleosides. 9 Ultraperformance liquid chromatography (UPLC) analyses identified the presence of adenosine in the micromolar concentration and that it was ubiquitously present in aqueous extracts of several pollens including birch, grass, ragweed, and pine pollen but not mugwort pollen. Notably, the authors demonstrated that pollen-derived adenosine stimulated an A2 receptor-dependent induction of cAMP and inhibited IL-12p70 induction in DCs, suggesting potent immunoregulatory activity. 9 In a follow-up study, Gilles-Stein et al 10 now report that these birch pollen-derived LMW compounds amplified allergen-specific immune responses in humans in vivo. The authors showed that skin prick test (SPT) reactions to pollen elicited larger wheals when allergens (native Phl p 1)
were tested together with the LMW compounds from pollen. Notably, similar results were obtained with candidate PALMs, including linoleic acid derivatives contained in aqueous pollen extracts of birch -9-HODE, 13-HODE, 9-HOTE, and 13-HOTE. The authors went on to show that nasal challenge of patients with allergies with an allergen (Phl p 1) plus Bet-APE < 3 kDa also increased the levels of cytokine production (IL-8) and IgE in the nasal lining fluids of patients allergic to birch and grass pollen. Notably, these patients had increased nasal secretion and reported more severe rhinorrhea than the group challenged with allergen only. Importantly, neither the Bet-APE < 3 kDa nor the linoleic acid derivatives induced any cutaneous allergic responses in the absence of allergen. 10 These data suggest that LMW compounds from pollen are not sufficient to induce an allergic response but can enhance the allergen-specific immune response in the skin and nose and are therefore of potential clinical relevance in patients with allergies. This knowledge will help to understand mechanisms of sensitization and sharpen therapeutic strategies involving pollen extracts.
| Costimulatory molecules in allergic sensitization and the resulting cascade
The induction of pollen sensitization is thought to be mediated by DC presentation of pollen allergens to na€ ıve CD4 + T cells in the draining lymph nodes, which promotes the development of an allergen-specific CD4 + type 2 response and orchestration of the allergic inflammatory cascade including allergen-specific IgE and mast cell (MC)-and eosinophil-dominant responses. 11, 12 A critical step for the DC-CD4 + type 2 cell polarization was the interaction of costimulatory molecules (CD28 and CD80/CD86; OX40L and OX40) between antigen-presenting cells (APCs) and T cells. 13 Recent studies indicate that interaction of APC-expressed OX40L and T cell-expressed OX40 is important for CD4 + Th 2 polarization and immune responses. 14, 15 Recent studies by Linhart and colleagues examined the effect of CD28 and CD40L neutralization by monoclonal antibody on IgE sensitization and development of allergic disease.
Employing a major timothy grass pollen allergen Phl p 5 allergy model, the authors demonstrated that blockade of CD40L (alone or together with CTLA4Ig) during the primary sensitization prevented the development of Phl p 5-specific Ig response and immediate-type reactions. 16 The suppressive effects of anti-CD40L (anti-CD154)
blockade were temporary and persisted until re-exposure to the same allergen. Anti-CD40L treatment of Phl p5-sensitized mice during the secondary allergen challenge phase had no effect on allergic secondary IgE responses. 16 Blocking CD28 (with CTLA4Ig) either during the sensitization or secondary allergen challenge phase had no detectable influence on the humoral response. 16 Thus, although "conventional" costimulation blockade suppressed the development of allergen-specific IgE during the primary antigen exposure, it did not lead to lasting tolerance. 16 In a follow-up study, the authors investigated whether blocking OX40 alone or in addition to "conven- 66 Conversely, approximately 50%-93% of patients with pollen allergy experience allergic symptoms following consumption of these cross-reactive BPrelated foods. 67 For nearly 2 decades, immunotherapy approaches (subcutaneous and sublingual) have been used to treat patients with birch pollen allergy with excellent efficacy and tolerance [68] [69] [70] [71] ; however, the effectiveness of BP allergen-specific immunotherapy on suppressing accompanying cross-reactive allergies is unclear. To 
| Food allergens
The rise in food allergies has provided impetus for various facets of molecular research related to food allergens. In particular, the rele- | 1517 cross-reactivity among different tree nuts. 86 This was accomplished by first mapping epitopes of the major cashew allergens Ana o 1 and Ana o 2, using an in vitro assay that detects allergen-specific CD4 + T cells based on their rapid activation by antigenic peptides. Analysis of T cell specificity using MHCII tetramers revealed a subset of cashew epitopes that cross-reacted with hazelnut and/or pistachio, but not walnut. The findings imply that a peptide vaccine using cashew peptides may confer some level of cross-protection against allergy to other tree nut allergens, but not walnut.
IgE antibodies against galactose-a-1,3-galactose (a-Gal) have been associated with severe anaphylactic reactions with first use of cetuximab and delayed anaphylactic reactions with red meat. Villalta et al have found a high prevalence of sIgE to a-Gal in people living in a rural village in the Italian Alps where there is a high exposure to ticks. 87 Further work is required to look at whether they are symptomatic with red meats.
There is strong evidence for the induction of tolerance to food allergens via the oral route. Intriguing new data from a randomized controlled trial suggested that maternal egg ingestion influences the concentration of ovalbumin in breastmilk and links to serum levels of egg-specific IgG4 in lactating infants. 88 This infers that maternal diet can influence the development of tolerance in children during an early window.
Once food allergy is established, oral immunotherapy strategies should minimize IgE binding to avoid side-effects, while retaining the capacity to activate T cells in order to induce tolerance. To this end, Tao et al 89 used mass spectrometry to monitor allergen peptides that resulted from boiling raw peanuts. Boiling for 12 hours was optimal for reducing IgE binding and generated short peptides amino acids in length) spanning significant regions of major allergens.
Notably, the resulting peanut preparation activated T cells to a similar degree as non-boiled raw peanut in cultures from peanut-allergic subjects. In a mouse model of shrimp allergy, oral administration of T cell epitopes of the major shrimp allergen, Met e 1, resulted in reduced specific IgE, as well as reduced eosinophils and goblet cells in the gut. 90 In tandem, increased blocking antibodies in the serum and enhanced expression of Th1/Treg-associated genes in the intestine were observed. These studies highlight the potential value of allergen-derived peptides to mitigate food allergy.
| EPID EMIOLOGY

| Exposure during pregnancy
During the last decades, there has been a substantial focus on the fetal uterointerine environment in relation to onset of allergy-related diseases in the offspring. During 2015, a number of scientific reports on this topic were published in our journal and so during 2016.
| Pufa
In a paper from the Generation R Study, the associations of maternal fatty acid levels during pregnancy with airway resistance and inflammation, asthma and eczema in school-age children were studied. 91 Almost 5000 mothers and their children were included in a population-based prospective cohort study. Plasma levels of glycerophospholipid fatty acid were during the second trimester of pregnancy and at the age of 6, airway resistance and inflammation were measured as well as exhaled nitric oxide (FeNO). Current physician-diagnosed asthma and eczema were assessed. Higher maternal total PUFA and total n-6 PUFA levels were associated with a significantly decreased risk of childhood asthma but with an increased risk of childhood eczema. The observed associations were partly explained by Linoleic acid (LA, C18:2n-6) levels. Maternal total n-3 PUFA levels and n-6/n-3 PUFA ratio were not associated with current asthma and eczema. No consistent associations of maternal total polyunsaturated fatty acid (PUFA), total n-6 PUFA, total n-3 PUFA levels and n-6/n-3 PUFA ratio during pregnancy were associated with child's Rint and FeNO. What the authors pointed out in this study was that intervention studies on time for publication of this report have been scarce and inconclusive, mostly due to small sample size, variability in dose and duration of supplementation, delay in the beginning of the supplementation during pregnancy or lactation, lack of variability in maternal dietary patterns, and short time period of follow-up. They concluded that new large randomized controlled trials using PUFA supplements from the earliest phases of pregnancy were needed.
| Vitamin D
The research group behind the Generation R cohort also investigated the associations of maternal and fetal 25-hydroxyvitamin D levels with childhood lung function and asthma. 92 For this study, data of a little more than 3 000 mothers including maternal blood samples in midgestation and umbilical cord blood samples at birth were used to 
| Antibiotics
Another area of interest has been the use of antibiotics during pregnancy or early infancy and its impact of developing childhood asthma due to the influence of antibiotics on the microbiota. In also a Dutch study, a case-sibling survey of 1 228 children with asthma and their 1 228 non-asthmatic siblings was undertaken. 93 Prescription of asthma medication was used as a proxy for asthma by the use of a representative prescription database including a motherinfant subset of approximately 40 000 mothers and their children.
The influence of confounding was controlled for. Antibiotic use in the third trimester of pregnancy was associated with a small increased risk of asthma in preschool children. The association was robust to time-invariant confounding or exposure time trends, further supporting the important role for early-life intestinal microbiota in the development of childhood asthma.
| Vitamin B3 (nicotinamide) and tryptophan
Within the UK Southampton Women Survey, Serum levels of kynurenine, kynurenic acid, anthranilic acid, tryptophan, nicotinamide, and N1-methylnicotinamide of 497 mothers were measured in late pregnancy and related to the odds ratio of infantile atopic eczema at ages 6 and 12 months. 94 Higher concentrations of nicotinamide and anthranilic acid were associated with a lower risk of eczema at age 12 months. The associations were robust to adjustment for potentially confounding variables. Their findings point to potentially modifiable maternal influences on this complex and highly prevalent condition of atopic eczema during infancy. 
| Maternal age
Abid et al 96 have examined asthma in an American study. Their results add more complexity to the maternal age/offspring asthma associations which are already complex and now in this study reveal opposite associations among Mexican American mothers compared to Caucasian mothers with a protective effect of young maternal age in this Latino group. Further study is required to untangle possible reasons for the association in this group.
| Ethnicity
Several interesting papers on migration and development of allergyrelated diseases have been published from Australia. Last year in Clinical and Experimental Allergy, Kate Allen and the team around her published reported on nut allergy prevalence differences between Asian-born children and Australian born children with Asian descent. 97 For their study, they used School Entrant Health Questionnaire administered to all 5-year-old children in Victoria, Australia.
The prevalence of parent-reported nut allergy (tree nut and peanut)
was assessed and whether this was altered by region of residence, socio-economic status, country of birth, or history of migration. They found that parent-reported nut allergy was more common among children born in Australia of Asian-born mothers than non-Asian children. Children born in Asia who subsequently migrated to Australia were at decreased risk of nut allergy. Parental migration from Asia to Australia appears to be an important risk factor in the development of nut allergy in the next generation, while being born in Asia is protective even with migration to Australia in early life.
In Denmark, differences in hospital attendance for anaphylaxis between immigrants and non-immigrants were investigated in a cohort. 98 A register-based, historical prospective cohort study was 
| Furry animals
In a Swedish cross-sectional study of adults 20-46 years and with data collected 2009-2012, the results of that data collection were compared to similar data collected from the same region and with the same age groups from 1991 to 1992, thus at least 17 years apart. 99 Between the 2 study periods, there was a significant increase in pollen sensitization whereas sensitization to other inhalant allergens remained unchanged. There was a significantly reduced risk of any allergic sensitization of growing up with livestock or furred pets. Growing up with livestock reduced the risk of sensitization to pollen allergens, or any of cat, dog, or horse allergens. The limitation of this study, in relation to risk factor analysis, is its crosssectional design and retrospective collection of data which is also pointed out by the authors.
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| Exposure to foods
In the Swedish population-based birth cohort study BAMSE of 4000 the incidence, characteristics and associated risks of anaphylaxis to foods among 16-year-olds. 100 They found that the incidence of food-induced anaphylaxis during adolescence in our populationbased birth cohort was higher than previously reported. Adolescents with anaphylaxis differ from adolescents with non-anaphylactic food-related symptoms with regard to culprit foods and sensitization.
Adolescents with previous anaphylaxis were likely to be polysensitized to foods, particularly tree nut and peanut storage proteins, and which warrants consideration at clinical follow-up. demonstrated that the delayed rise in exhaled NO is from increased flux from the airway wall to the lumen rather than alveolar production and was confined to those exposed and who showed a constrictor response. The clinical upshot is that monitoring simple exhaled NO should be a good a marker of isocyanate inflammation.
Finally, Al-shamkhi et al 104 have confirmed that the previously reported environmental and demographic factors that influence FeNO in healthy populations also apply to those with mild asthma.
Two novel additional factors, age of menarche and parental smoking, also appear to lower FeNO in this population. Overwhelmingly though atopy appears to be the major driver of FeNO in this population from the Swedish GA2LEN study.
| Bronchial hyperresponsiveness
Sverrild et al 105 have related mannitol and methacholine airway responsiveness to specific mast cell phenotypes (specifically tryptase and chymase-positive mast cells) and mannitol AR to eosinophilic airway inflammation in the submucosa in ICS free asthmatics. It is not clear though if these associations are causal. If they prove to be causally associated, this would suggest that mannitol AHR might be a more useful marker of eosinophilic airway inflammation than methacholine or other direct agents.
| Biomarkers
There is a rapidly growing literature on the search for new useful serum and salivary biomarkers of asthma. Clusterin is a ubiquitous antioxidant glycoprotein. In a study by Soi et al, 106 salivary levels of clusterin were elevated in asthmatic children compared to controls and levels were positively correlated with clinical severity particularly children with eosinophilic asthma. Interestingly, salivary levels were reduced in children with asthma exacerbations possible related to clusterin "consumption" by oxidants or the use of systemic corticosteroids.
This effect may reduce the clinical value of clusterin as an asthma marker.
Periostin is now one of the more studied asthma biomarkers. In this population, Caswell-Smith et al explore normal ranges (wide)
in an adult population without asthma or COPD. 107 Median levels in this population were similar to previous studies among subjects with asthma and severe asthma suggesting that periostin is not driven by asthma-related pathology and is not a useful marker of disease or disease severity.
| Psychological factors
That asthma is both depressing and anxiety inducing, has been the subject of a number of studies, and perhaps is not all that surprising.
In a large twin study from the Swedish Twin Register, Tedner et al largely confirm these previous findings and are able to demonstrate that the effect is not likely to be genetic or due to environment and probably not related to ICS treatment. 108 
| Severe asthma
Cluster analyses are being brought to bear on more complex clinical issues. In this paper, Seikiya et al confirm previous observations that severe asthma exacerbations arise in clusters with underlying severity, in those with multiple comorbidities especially among women, those not using ICS and interestingly among symptomatically mild patients who had had a previous hospital admission for asthma, one of the strongest predictors of severe exacerbations. 109 In a longitudinal study of severe poorly controlled asthma, Walsh et al 110 showed that sputum eosinophilia (but not sputum neutrophilia) is a strong predictor of asthma exacerbations. This supports the clinical experience with these severe allergic patients. The neutrophil findings, or neutrophil phenotype, may be a marker of previous eosinophilic asthma that is better treated, or with better adherence or response to corticosteroids.
In a Xolair registry study, Hew et al 111 reported that 31% of patients were above the 750 mg dosing range (by weight and/or IgE) which would exclude them in some jurisdictions and mean that they would receive higher doses in other jurisdictions. This study suggested that these patients benefit equally using the 750 mg cut-off and that they should be included and that higher doses may not be required. 
| Air pollution
In this large single city study over a decade, Chen et al present data
showing that increments of a variety of air pollutants and pollens were associated with increased hospital admission. 114 This was especially seen with PM 2.5 (30% increase in admissions for a 10 unit increase) and a far greater effect in children compared to adults.
These effects are also related to season and temperature which differ for different pollutants. There was no obvious interaction between pollens and pollutants as has been found in other studies.
Presumably, the future maybe real-time risk predictions that can be met with increased treatment. 120 showed that advice to eat nuts to which a child is not allergic was not followed at home, perhaps due to anxiety about the possibility of a severe reaction occurring in the home environment-however, a supervised food challenge was followed by home introduction in most cases. relation to BSACI guidelines. 123 They found reasonable adherence to the guidance, but a notable variation in adherence to the recommendation to use skin testing as the first-line investigation. Hence, allergists are not consistently using the most reliable testing method for hymenoptera allergy. In this context, it is interesting to note that a study from Slovenia found evidence that component testing for bee venom (rApim1) and yellow jacket wasp venom (rVesv5) using recombinant LITE products, performed well compared with Immuno-CAP recombinant allergens, or native allergens; this potentially avoids the issue of cross-reactive carbohydrate determinants which has been reported with use of native allergens for venom IgE testing. 124 However, as with many previous reports of IgE testing in different scenarios, no comparison with skin testing was made, which is the current first-line investigation according to BSACI guidance.
| Allergy diagnosis
Moreover, the authors found no association between IgE levels and severity of reaction. Where skin and intradermal testing is not contra-indicated, it remains the preferred diagnostic test for hymenoptera allergy due to its high sensitivity.
Kespohl et al, 125 studying mould allergy, found improved diagnostic sensitivity from skin prick testing than from specific IgE ROBERTS ET AL.
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Diagnosis of perioperative anaphylaxis can also be difficult, and
Egner et al 126 highlighted several specific issues with the sensitivity of current mast cell tryptase assays in their review of 17 years of UK data. Burk et al, reporting immunologic findings from a study of peanut sublingual immunotherapy, found a prognostic role for IgE allergy tests; they showed that lower specific IgE to peanut, to Ara h2 or to Ara h3 was all associated with increased probability of successful desensitization during treatment. 127 
| Drug allergy and urticaria
In a retrospective review of allergy testing following apparent immediate-type reactions to iodinated contrast media, Sese et al found a reasonable negative predictive value from skin prick and intradermal testing; however, they did identify patients who appeared to pass an intravenous challenge test, but later reaction to contrast media again. 128 This supports international recommendations to consider repeat allergy testing in patients with a high likelihood of drug allergy (at least for beta-lactam allergy), including drug provocation testing, even if they pass the initial challenge test. 129 Park et al Maurer et al, 132 in a systematic review of the literature, found good evidence for an association between chronic spontaneous urticaria and systemic lupus erythematosus. In the majority of cases urticarial preceded the diagnosis of systemic lupus erythematosus, thereby justifying screening for lupus in patients presenting with chronic spontaneous urticarial; however, the authors caution that the evidence base is insufficiently strong to reliably quantify the association between these disorders at present.
Jepsen et al 133 reported data from the COPSAC cohort studies
showing that a breast milk inflammatory mediator pattern dominated by interleukin 1 beta was associated with reduced risk of eczema in offspring. This is not the first report of breast milk analytes associated with altered inflammatory disease risk in infants, but there is little consistency in outcomes or replication of findings in this area of study to date.
| CONCLUSIONS
The year 2016 was another interesting year in the field of allergy with advances across our understanding across many areas. We look forward to further interesting data in 2018.
